Literature DB >> 9988275

Taming of transposable elements by homology-dependent gene silencing.

S Jensen1, M P Gassama, T Heidmann.   

Abstract

Transposable elements can invade virgin genomes within a few generations, after which the elements are 'tamed' and retain only limited transpositional activity. Introduction of the I element, a transposon similar to mammalian LINE elements, into Drosophila melanogaster genomes devoid of such elements initially results in high-frequency transposition of the incoming transposon, high mutation rate, chromosomal nondisjunction and female sterility, a syndrome referred to as hybrid dysgenesis (for review, see refs 2-4); a related syndrome has also been described in mammals. High-frequency transposition is transient, as the number of I elements reaches a finite value and transposition ceases after approximately ten generations. It has been proposed that the I elements encode a factor that negatively regulates their own transcription, but evidence for such a mechanism is lacking. Using the hybrid dysgenesis syndrome in Drosophila as a model, we show here that transpositional activity of the I element can be repressed by prior introduction of transgenes expressing a small internal region of the I element. This autoregulation presents features characteristic of homology-dependent gene silencing, a process known as cosuppression. Repression does not require any translatable sequence, its severity correlates with transgene copy number and it develops in a generation-dependent manner via germline transmission of a silencing effector in females only. These results demonstrate that transposable elements are prone to and can be tamed by homology-dependent gene silencing, a process that may have emerged during the course of evolution as a specific defense mechanism against these elements.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988275     DOI: 10.1038/5997

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  72 in total

1.  Cosuppression of I transposon activity in Drosophila by I-containing sense and antisense transgenes.

Authors:  S Jensen; M P Gassama; T Heidmann
Journal:  Genetics       Date:  1999-12       Impact factor: 4.562

2.  RNA interference is mediated by 21- and 22-nucleotide RNAs.

Authors:  S M Elbashir; W Lendeckel; T Tuschl
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

3.  The end of the LINE?: lack of recent L1 activity in a group of South American rodents.

Authors:  N C Casavant; L Scott; M A Cantrell; L E Wiggins; R J Baker; H A Wichman
Journal:  Genetics       Date:  2000-04       Impact factor: 4.562

4.  Determination of L1 retrotransposition kinetics in cultured cells.

Authors:  E M Ostertag; E T Prak; R J DeBerardinis; J V Moran; H H Kazazian
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

5.  A DNA target of 30 bp is sufficient for RNA-directed DNA methylation.

Authors:  T Pélissier; M Wassenegger
Journal:  RNA       Date:  2000-01       Impact factor: 4.942

6.  Artificial and epigenetic regulation of the I factor, a nonviral retrotransposon of Drosophila melanogaster.

Authors:  E Gauthier; C Tatout; H Pinon
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

7.  New insights on homology-dependent silencing of I factor activity by transgenes containing ORF1 in Drosophila melanogaster.

Authors:  S Malinsky; A Bucheton; I Busseau
Journal:  Genetics       Date:  2000-11       Impact factor: 4.562

8.  P-Element repression in Drosophila melanogaster by a naturally occurring defective telomeric P copy.

Authors:  L Marin; M Lehmann; D Nouaud; H Izaabel; D Anxolabéhère; S Ronsseray
Journal:  Genetics       Date:  2000-08       Impact factor: 4.562

Review 9.  The rest is silence.

Authors:  E Bernstein; A M Denli; G J Hannon
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

Review 10.  RNA-directed DNA methylation.

Authors:  M Wassenegger
Journal:  Plant Mol Biol       Date:  2000-06       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.